Professor | Jing Liu | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Jing Liu
Contact Information	liujing212@fudan.edu.cn
Language ability	Chinese, English
Province	Shanghai

Upload Avatar (500 x 500)

Name

Jing Liu

Contact Information

liujing212@fudan.edu.cn

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	Fudan University
Faculty	Basic Medical Sciences
Academic Background & Achievements	1992.09—1996.06 Bachelor's in Molecular Biology: Nankai University 1996.09—2002.04 Ph.D. in Biochemistry and Molecular Biology: Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences
Work Experience	2002.04—2007.09 Assistant Researcher - Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences 2007.09—2014.12 Assistant Researcher - Institute of Biomedical Sciences/School of Basic Medical Sciences, Fudan University 2014.12—Present Associate Professor - Institute of Biomedical Sciences/School of Basic Medical Sciences, Fudan University

University/Lab Affiliation and Title

Fudan University

Faculty

Basic Medical Sciences

Academic Background & Achievements

1992.09—1996.06 Bachelor's in Molecular Biology: Nankai University
1996.09—2002.04 Ph.D. in Biochemistry and Molecular Biology: Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences

Work Experience

2002.04—2007.09 Assistant Researcher - Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences
2007.09—2014.12 Assistant Researcher - Institute of Biomedical Sciences/School of Basic Medical Sciences, Fudan University
2014.12—Present Associate Professor - Institute of Biomedical Sciences/School of Basic Medical Sciences, Fudan University

Areas of Focus	Molecular Biology of Hepatitis B Virus (HBV) Molecular Virology Immunology HBV Animal Models and Drug Development Recombinant HBV Vector Systems and Applications Viral Bioinformatics Ancient and Emerging Viruses Regulation of Liver Gene Expression Mechanisms of Liver Cancer and Other Tumors Drug Research
Publications	High mobility group AT-hook 1 (HMGA1) is an important positive regulator of hepatitis B virus (HBV) that is reciprocally upregulated by HBV X protein., Shen, Z., Wu, J., Gao, Z., Zhang, S., Chen, J., He, J., Guo, Y., Deng, Q., Xie, Y., Liu, J., Zhang, J., 2022 Characterization of IL-21-expressing recombinant hepatitis B virus (HBV) as a therapeutic agent targeting persisting HBV infection., Shen, Z., Wu, J., Gao, Z., Wang, J., Zhu, H., Mao, R., Wang, X., Zhang, J., Xie, Y., Liu, J., 2020 Restriction of exogenous DNA expression by SAMHD1., Gu, C., Ming, L., Fang, Y., Liu, X., Zhang, J., Zelinskyy, G., Deng, Q., Liu, J., Xie, Y., 2020 IL-21-based therapies induce clearance of hepatitis B virus persistence in mouse models., Shen, Z., Liu, J., Wu, J., Zhu, Y., Li, G., Wang, J., Luo, M., Deng, Q., Zhang, J., Xie, Y., 2019 Hepatitis B virus persistence in mice reveals IL-21 and IL-33 as regulators of viral clearance., Shen, Z., Yang, H., Yang, S., Wang, W., Cui, X., Zhou, X., Liu, W., Pan, S., Liu, Y., Zhang, J., Zhang, J., Xie, Y., Liu, J., 2017 Prospero-related homeobox 1 drives angiogenesis of hepatocellular carcinoma through selectively activating IL-8 expression., Liu, Y., Zhang, Y., Wang, S., Dong, Q. Z., Shen, Z., Wang, W., Tao, S., Gu, C., Liu, J., Xie, Y., Qin, L. X., 2017 Association of Mutations in Toll-like Receptor 2 Signaling Genes With Fulminant Form of Hepatitis B-Related Acute Liver Failure., Han, Y., Gu, L., Liu, J., Li, X., Wang, M., Gong, Q., Yu, D., Yang, Z., Zhang, D., Yang, H., Shen, Z., Zhu, H., Xie, Y., Zhang, X., 2017 Re-Designed Recombinant Hepatitis B Virus Vectors Enable Efficient Delivery of Versatile Cargo Genes to Hepatocytes with Improved Safety., Bai, W., Cui, X., Chen, R., Tao, S., Hong, R., Zhang, J., Zhang, J., Wang, Y., Xie, Y., Liu, J., 2016 PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing beta-catenin expression and nuclear translocation., Liu, Y., Ye, X., Zhang, J.B., Ouyang, H., Shen, Z., Wu, Y., Wang, W., Wu, J., Tao, S., Yang, X., Qiao, K., Zhang, J., Liu, J., Fu, Q., Xie, Y., 2015 Quantitative Proteomic Analysis of Exosome Protein Content Changes Induced by Hepatitis B Virus in Huh-7 Cells Using SILAC Labeling and LC-MS/MS., Zhao, X., Wu, Y., Duan, J., Ma, Y., Shen, Z., Wei, L., Cui, X., Zhang, J., Xie, Y., Liu, J., 2014

Areas of Focus

Molecular Biology of Hepatitis B Virus (HBV)
Molecular Virology
Immunology
HBV Animal Models and Drug Development
Recombinant HBV Vector Systems and Applications
Viral Bioinformatics
Ancient and Emerging Viruses
Regulation of Liver Gene Expression
Mechanisms of Liver Cancer and Other Tumors
Drug Research

Publications

High mobility group AT-hook 1 (HMGA1) is an important positive regulator of hepatitis B virus (HBV) that is reciprocally upregulated by HBV X protein., Shen, Z., Wu, J., Gao, Z., Zhang, S., Chen, J., He, J., Guo, Y., Deng, Q., Xie, Y., Liu, J., Zhang, J., 2022
Characterization of IL-21-expressing recombinant hepatitis B virus (HBV) as a therapeutic agent targeting persisting HBV infection., Shen, Z., Wu, J., Gao, Z., Wang, J., Zhu, H., Mao, R., Wang, X., Zhang, J., Xie, Y., Liu, J., 2020
Restriction of exogenous DNA expression by SAMHD1., Gu, C., Ming, L., Fang, Y., Liu, X., Zhang, J., Zelinskyy, G., Deng, Q., Liu, J., Xie, Y., 2020
IL-21-based therapies induce clearance of hepatitis B virus persistence in mouse models., Shen, Z., Liu, J., Wu, J., Zhu, Y., Li, G., Wang, J., Luo, M., Deng, Q., Zhang, J., Xie, Y., 2019
Hepatitis B virus persistence in mice reveals IL-21 and IL-33 as regulators of viral clearance., Shen, Z., Yang, H., Yang, S., Wang, W., Cui, X., Zhou, X., Liu, W., Pan, S., Liu, Y., Zhang, J., Zhang, J., Xie, Y., Liu, J., 2017
Prospero-related homeobox 1 drives angiogenesis of hepatocellular carcinoma through selectively activating IL-8 expression., Liu, Y., Zhang, Y., Wang, S., Dong, Q. Z., Shen, Z., Wang, W., Tao, S., Gu, C., Liu, J., Xie, Y., Qin, L. X., 2017
Association of Mutations in Toll-like Receptor 2 Signaling Genes With Fulminant Form of Hepatitis B-Related Acute Liver Failure., Han, Y., Gu, L., Liu, J., Li, X., Wang, M., Gong, Q., Yu, D., Yang, Z., Zhang, D., Yang, H., Shen, Z., Zhu, H., Xie, Y., Zhang, X., 2017
Re-Designed Recombinant Hepatitis B Virus Vectors Enable Efficient Delivery of Versatile Cargo Genes to Hepatocytes with Improved Safety., Bai, W., Cui, X., Chen, R., Tao, S., Hong, R., Zhang, J., Zhang, J., Wang, Y., Xie, Y., Liu, J., 2016
PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing beta-catenin expression and nuclear translocation., Liu, Y., Ye, X., Zhang, J.B., Ouyang, H., Shen, Z., Wu, Y., Wang, W., Wu, J., Tao, S., Yang, X., Qiao, K., Zhang, J., Liu, J., Fu, Q., Xie, Y., 2015
Quantitative Proteomic Analysis of Exosome Protein Content Changes Induced by Hepatitis B Virus in Huh-7 Cells Using SILAC Labeling and LC-MS/MS., Zhao, X., Wu, Y., Duan, J., Ma, Y., Shen, Z., Wei, L., Cui, X., Zhang, J., Xie, Y., Liu, J., 2014

Hbv Molecular Biology Virology Immunology Animal Models Drug Development Recombinant Vectors Bioinformatics Ancient Viruses Liver Cancer

Weibin Wang - Peking University

Huanran Tan - Peking University

Zhang Peng - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us